The September 24, 2015 London Daily Mail headline said it best for this financial boy-wonder jerk.
Meet the most despised man in the world: Global outrage as 32-year-old ex-hedge funder buys rights to AIDS drug and promptly raises price overnight by 5500% – from $13.50 to $750.00 per pill”
Martin Shkreli is famous for moving from job to job, buying up old pill recipes and then jacking up the price. In his latest job as CEO of Turing Pharmceuticals, he purchased the rights to Daraprim. The drug treats life-threatening parasitic infections and costs about a buck-a-pill to manufacture. Marty says the price hike is necessary to pay for new product development. While that argument certainly has some logic behind it, our guess is this loathsome jerk will use most of the proceeds to line his pockets as well as the pockets of his like-minded business kin – thus marking another defining moment in the march toward a single-payer health system in the United States. While that probably isn’t Marty’s goal, it may be his legacy.